newsfilter
← Latest News
ACCESS Newswire·

NLS Pharmaceutics to Participate in 2022 BIO CEO & Investor Conference

ZURICH, SWITZERLAND / ACCESSWIRE / February 11, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for pati